PD-1 blockade reverts motility arrest of transferred tumor-infiltrating CD8+T cells in adoptive cell transfer immunotherapy

被引：0
|
作者：
Mehta, Gautam [1 ,2 ]
Sukumar, Madhuhasan [2 ]
McGavern, Dorian [3 ]
Restifo, Nicholas [2 ]
机构：
[1] NINDS, Surg Neurol Branch, Bethesda, MD 20892 USA
[2] NCI, Surg Branch, Bethesda, MD 20892 USA
[3] NINDS, Viral Immunol & Intravital Imaging Sect, Bethesda, MD 20892 USA
来源：
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
TUM7P.1014
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Assessment of PD-L1, TGF-β Expression and Tumor-Infiltrating CD8+T Cells in Advanced Thymic Epithelial Tumors
    Wang, Jie
    Chen, Han
    Bai, Hua
    Zhao, Jun
    Wang, Shuhang
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S351 - S351
  • [32] Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells
    Wang, Shu
    Campos, Jose
    Gallotta, Marilena
    Gong, Mei
    Crain, Chad
    Naik, Edwina
    Coffman, Robert L.
    Guiducci, Cristiana
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (46) : E7240 - E7249
  • [33] Blockade of PD-1/PD-L1 Interactions is Paradoxically Detrimental in a T Cell Adoptive Transfer Tumor Therapy Model
    Zhang, Long
    Gajewski, Thomas F.
    Kline, Justin
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 969 - 969
  • [34] Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+T cells in deficient mismatch repair colorectal cancer
    Sui, Qiaoqi
    Liu, Dingxin
    Jiang, Wu
    Tang, Jinghua
    Kong, Lingheng
    Han, Kai
    Liao, Leen
    Li, Yuan
    Ou, Qingjian
    Xiao, Binyi
    Liu, Guochen
    Ling, Yihong
    Chen, Jiewei
    Liu, Zexian
    Zuo, Zhixiang
    Pan, Zhizhong
    Zhou, Penghui
    Zheng, Jian
    Ding, Pei-Rong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [35] Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment
    Blake, Stephen J. P.
    Ching, Alan L. H.
    Kenna, Tony J.
    Galea, Ryan
    Large, Justin
    Yagita, Hideo
    Steptoe, Raymond J.
    PLOS ONE, 2015, 10 (03):
  • [36] Functional tumor specific CD8+T cells in spleen express a high level of PD-1
    Wang, Zili
    Chen, Ting
    Lin, Wanzun
    Zheng, Weili
    Chen, Junying
    Huang, Fei
    Xie, Xianhe
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [37] Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells
    Berrien-Elliott, Melissa M.
    Yuan, Jinyun
    Swier, Lauryn E.
    Jackson, Stephanie R.
    Chen, Collin L.
    Donlin, Maureen J.
    Teague, Ryan M.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (02) : 116 - 124
  • [38] PD-1 Blockade Unleashes Effector Potential of Both High- and Low-Affinity Tumor-Infiltrating T Cells
    Martinez-Usatorre, Amaia
    Donda, Alena
    Zehn, Dietmar
    Romero, Pedro
    JOURNAL OF IMMUNOLOGY, 2018, 201 (02): : 792 - 803
  • [39] MLXIPL associated with tumor-infiltrating CD8+T cells is involved in poor prostate cancer prognosis
    Fan, Yuanming
    Ge, Yuqiu
    Niu, Kaiming
    Li, Ying
    Qi, Lian-Wen
    Zhu, Haixia
    Ma, Gaoxiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] Serum-derived exosomal PD-L1 and tumor-infiltrating CD8+T cell expression for predicting anti-PD-1 response in NSCLC
    Shimada, Yoshihisa
    Matsubayashi, Jun
    Kudo, Yujin
    Ohira, Tatsuo
    Ikeda, Norihiko
    CANCER SCIENCE, 2021, 112 : 370 - 370
12345